Welcome to the Winter edition of European Oncology & Haematology . This edition, expertly introduced by Paolo Ascierto, features a wide range of timely and concise review articles on some of the most important topics in the field including breast cancer, lung cancer, multiple myeloma, lymphoma and haematology. In the lung cancer section Rolfo et al discuss adverse event management in ALK+ non-small cell lung cancer and Vansteenkiste et al explore the future of vaccines in lung cancer. Haematological malignancies are a key theme within this issue with a selection of topical articles. Richardson et al review pomalidomide in the treatment of relapsed/refractory multiple myeloma and Jager and Hutchings discuss antibody-drug conjugates in relapsed/refractory CD30-positive lymphomas. We hope this new collection of articles provide useful information relevant to your practice and interests. Enjoy!